A review of Dr. Matthias Rath’s Theory On Winning War On Cancer. The proof.
The Collagen Destruction Theory. Part 2
In the previous post, we have seen how he collagen digesting mechanism is typical of all forms of cancers whatever their origin.
For instance, let’s see how this process takes place in the cells of the liver. The liver is responsible for neutralizing and removing toxins of any kind from the body. therefore being continuously exposed to these poisonous substances its cells can be permanently damaged or destroyed.
Unfortunately, not only toxins but also many synthetic pharmaceutical drugs are among the most common causes of liver cancer.
The damage these substances do to the liver cells leads to a permanently re-programming’ of the cell’s DNA (the genetic material)
Such re-programming activates a series of biological steps that marks the beginning of the cancer process and eventually lead to full-blown cancer.
Two events take place at that point:
- Cells start multiplicating uncontrollably.basically becoming immortal and multiplying indefinitely.
- These cells now mass produce collagen-dissolving enzymes.
The more collagen digesting enzymes will be produced, the more aggressive and faster spreading cancer becomes, and the shorter the life expectancy of the patient becomes if the mechanism is not stopped.
A WAY TO BLOCK THIS DESTRUCTIVE PROCESS
Besides the body’s intrinsic enzymatic block that can stop the action of collagen-digesting enzymes, nature itself provides us with two large groups of molecules that can block the collagen dissolving mechanism.
The first group is the body’s intrinsic enzymatic block that can stop the action of the collagen-digesting enzymes.
The second group of enzyme-blocking substances comes from our diet or as dietary supplements.
The most important micro nutrient from our diet is the natural amino acid L-lysine.
When a sufficient amount of lysine is supplied as a dietary supplement, it can block the anchor sites by which collagen dissolving enzymes bind to connective tissue molecules. Lysine thus prevents these enzymes from uncontrollably dissolving connective tissue.
Lysine can inhibit the collagen digesting enzymes, the uncontrolled degradation of collagen and, thereby, impede the spread of cancer.
AMINOACID LYSINE AS A NATURAL ENZYME BLOCK
They are made of the amino group (NH2), the carboxyl group (COOH) and a side chain containing carbon, hydrogen or oxygen; two amino acids (cysteine and methionine) also contain sulfur and one (selenocysteine) contains selenium.
Our bodies use various combinations of amino acids to create peptides (a compound consisting of two or more amino acids linked in a chain) and proteins.
All the proteins in our bodies are composed of some twenty-one known amino acids that function like the letters of the alphabet: we can compare the single amino acids to the letter of the alphabet, the peptides to words and the proteins to sentences,
The cells of the body can produce most amino acids themselves. These are called ‘non-essential’ amino acids (arginine, cysteine, glutamine, glycine, proline, serine, tyrosine, alanine, asparagine, aspartic acid, glutamic acid, selenocysteine)
But, there are nine known amino acids that our body cannot produce and have to be supplied through the diet. These are called ‘essential’ amino acids. and Lysine is one of them (histidine, isoleucine, leucine, lysine methionine, phenylalanine, threonine, tryptophan, valine).
Among its many functions, lysine is also the basic building block of the amino acid carnitine, which is important for energy metabolism in every cell.
The daily requirement for lysine surpasses that of all other amino acids because about 25 percent of collagen, the most abundant and important structural molecule of bones, skin, blood vessel walls, and all other organs, consists of two amino acids: lysine and proline.
Even taking large quantities of lysine will not cause adverse effects since our body is familiar with this molecule and will simply excrete any amount not needed.
VITAMIN C AND LYSINE
The stability of our connective tissue is determined by two main factors:
- an optimum production of collagen and
- the prevention of uncontrolled tissue degradation.
Besides lysine, vitamin C is another essential micronutrient for our body. These two micro nutrients together help in controlling cancer and other diseases by providing stability of the connective tissue, specifically:
1. Vitamin C stimulates the production of collagen and other connective tissue molecules and is essential for their optimal structure. Vitamin C assures optimal production of collagen and elastin fibers and contributes to strong connective tissue.
Optimum production of connective tissue promotes the encapsulation, the biological confinement, of tumors.
2. Lysine prevents enzymatic digestion of collagen molecules thus inhibiting the destruction of connective tissue. At the same time, it provides an essential building block of collagen in the body.
Because the human body neither produces Lysine nor vitamin C, and doesn’t get them in sufficient quantity of these essential micronutrients through our modern diet, almost every person in the western world suffers from long-term insufficiency of these essential micronutrients.
OPTIMAL PRODUCTION OF HEALTHY COLLAGEN ESSENTIAL FOR PREVENTION AND CONTROL OF CANCER AND OTHER DISEASES.
So, healthy collagen molecules are the basis for effective control of cancer and other diseases. And optimal production and structure of collagen critically depend on three micro nutrients:
– Vitamin C. Controls collagen production at the level of the cell nucleus. In addition, newly formed collagen strands, need this vitamin to attain the optimum stability of collagen.
vitamin C ALSO catalyzes the formation of chemical ‘bridges’ between separate collagen fibers, thus stabilizing the entire structure.
– Lysine. A building block of the amino acid chain that forms the collagen protein molecule.
-Proline. Also an important building block of collagen. In contrast to lysine, proline can be produced by our body, but only in limited amounts.
The body’s capacity to produce proline can be exhausted in a person suffering from a chronic disease – associated with long-term enzymatic degradation of collagen. The consequence of this reduced production is tissue weakness, which, in turn, facilitates disease progression.
THE ROLE OF VITAMIN C AS ENCAPSULATOR OF TUMORS HAS BEEN PROOVED AT THE RATH INSTITUTE.
The researchers of the Institute wanted to study the intriguing question of whether it is possible that one factor alone, the presence of vitamin C in optimum amounts, can decide about the inhibition of tumor development.
They developed a mouse model that was unable to produce vitamin C in its body. By this genetic variation, the ‘genetic defect’ that affects all humans today was exactly mimicked.
For the subsequent experiment, they divided the animals unable to produce their own vitamin C into two groups. Then the animals of both groups were challenged with skin cancer (melanoma) cells.
Subsequently, they placed one group of these animals on a diet containing optimum amounts of vitamin C, while the other group received a diet deficient in this essential nutrient.
The dramatic results of this study documented for the first time in this experiments demonstrated that:
- The animals with dietary vitamin C deficiency developed large tumors, which were growing diffusely into the neighboring tissue (picture A).
- In contrast, the animals supplemented with vitamin C developed fewer and smaller tumors. Most remarkably, optimum vitamin C in the diet led to the formation of connective tissue confinement (Encapsulations) of the tumors in this group (picture B).
This experiment shows that the presence or absence of vitamin C is a decisive factor stimulating the body’s defense against cancer tumors.
This medical breakthrough, this victory over cancer through natural, not patentable means, was published in the USA Today, on March 8, 2002.
Obviously, for pharmaceutical-oriented medicine and for the ‘business with chemotherapy’ these findings posed a fundamental threat. and not surprisingly, it was met from that side with indifference and even resistance.
A resistance that has been decisively weakened by a large amount of research data published by the Rate Institute and by many studies worldwide that followed their initial public announcement in USA Today in 2002 (see graph).
In the next post will take an overview of their research that is cracking the half-century old fortress of the pharmaceutical monopoly with chemotherapy and radiation in cancer
Until next time.